The Acute Impact of Sit-stand Desks on Post-meal Blood Sugar Levels
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02913079|
Recruitment Status : Recruiting
First Posted : September 23, 2016
Last Update Posted : October 26, 2017
|Condition or disease||Intervention/treatment||Phase|
|Insulin Sensitivity Glucose Tolerance Sedentary Behaviour Physical Activity||Behavioral: Sit-stand desk Behavioral: Sitting desk||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||25 participants|
|Intervention Model:||Crossover Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Basic Science|
|Official Title:||The Acute Impact of Sit-stand Desks on Post-meal Blood Sugar Levels|
|Study Start Date :||September 2016|
|Estimated Primary Completion Date :||June 2018|
|Estimated Study Completion Date :||September 2018|
Experimental: Sit-stand desk
During this condition, participants will sit or stand as much as they like throughout a workday.
Behavioral: Sit-stand desk
Placebo Comparator: Sitting
During this condition, participants will work in the sitting position only.
Behavioral: Sitting desk
- Postprandial Glucose [ Time Frame: 12 hours ]Postprandial glucose will be assessed over 1 workday in both the experimental and control conditions.
- Objectively measured minutes of light, moderate and vigorous physical activity. [ Time Frame: 24 hours ]Physical activity time will be assessed over 1 workday during both conditions.
- Objectively measured minutes of sitting [ Time Frame: 24 hours ]Sitting time will be assessed over 1 workday during both conditions.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02913079
|Contact: Travis J Saunders, PhD||902 566 firstname.lastname@example.org|
|Contact: Travis Saunders, PhDemail@example.com|
|Canada, Prince Edward Island|
|University of Prince Edward Island||Recruiting|
|Charlottetown, Prince Edward Island, Canada, C1A 4P3|
|Contact: Travis J Saunders, PhD 902 566 0641 firstname.lastname@example.org|